ANTX
AN2 Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.00
+0.20 (+4.17%)
Rating:C
Company Profile
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$4.90
Prev. Close
$4.80
Day Low
$4.87
Day High
$5.08
52W Low
$1.00
52W High
$6.91
Market Cap
$0.14B
Volume
0.24M